SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General statement of acquisition of beneficial ownership:
SEC Accession No. 0000902664-22-002385
Filing Date
2022-04-01
Accepted
2022-04-01 06:00:40
Documents
1

Document Format Files

Seq Description Document Type Size
1 ADAGIO THERAPEUTICS, INC. p22-1210sc13d.htm SC 13D 87158
  Complete submission text file 0000902664-22-002385.txt   88659
Mailing Address 700 CANAL STREET, 2ND FLOOR STAMFORD CT 06902
Business Address 700 CANAL STREET, 2ND FLOOR STAMFORD CT 06902 203-516-3730
M28 Capital Management LP (Filed by) CIK: 0001807489 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D

Mailing Address 1601 TRAPELO ROAD SUITE 178 WALTHAM MA 02451
Business Address 1601 TRAPELO ROAD SUITE 178 WALTHAM MA 02451 (781) 819-0080
Adagio Therapeutics, Inc. (Subject) CIK: 0001832038 (see all company filings)

IRS No.: 851403134 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-92804 | Film No.: 22795651
SIC: 2836 Biological Products, (No Diagnostic Substances)